These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21645594)

  • 1. Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.
    Jiang Y; Jiang X; Law K; Chen Y; Gu J; Zhang W; Xin H; Sha X; Fang X
    Int J Pharm; 2011 Aug; 415(1-2):252-8. PubMed ID: 21645594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation.
    Jiang Y; Sha X; Zhang W; Fang X
    Int J Pharm; 2010 Sep; 397(1-2):116-21. PubMed ID: 20637848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity.
    Huang XH; Xiong PC; Xiong CM; Cai YL; Wei AH; Wang JP; Liang XF; Ruan JL
    Phytomedicine; 2010 Oct; 17(12):930-4. PubMed ID: 20381325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of polyrotaxane-camptothecin conjugates and evaluation of its anti-tumor effect].
    Lai CL; Lai L; Zhao JB; Chen JH
    Yao Xue Xue Bao; 2010 Jul; 45(7):920-5. PubMed ID: 20931793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio.
    Chen J; Hu RR; Yang XX; Gu W; Tian R; Gong F; Luo L; Fang F; Chen ZP; Cai BC
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):925-9. PubMed ID: 23934323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
    Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
    Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
    Nekkanti V; Karatgi P; Paruchuri S; Pillai R
    Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and antitumor study of camptothecin nanocrystals.
    Zhang H; Hollis CP; Zhang Q; Li T
    Int J Pharm; 2011 Aug; 415(1-2):293-300. PubMed ID: 21679755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity.
    Yao L; Zhao X; Li Q; Zu Y; Fu Y; Zu B; Meng X; Liu C
    Int J Pharm; 2012 Feb; 423(2):586-8. PubMed ID: 22193057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
    Minelli R; Cavalli R; Ellis L; Pettazzoni P; Trotta F; Ciamporcero E; Barrera G; Fantozzi R; Dianzani C; Pili R
    Eur J Pharm Sci; 2012 Nov; 47(4):686-94. PubMed ID: 22917641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effects of raddeanin A on S180, H22 and U14 cell xenografts in mice].
    Wang MK; Ding LS; Wu FE
    Ai Zheng; 2008 Sep; 27(9):910-3. PubMed ID: 18799026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Lawson KA; Anderson K; Snyder RM; Simmons-Menchaca M; Atkinson J; Sun LZ; Bandyopadhyay A; Knight V; Gilbert BE; Sanders BG; Kline K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of 20-O-linked nitrogen-based camptothecin ester derivatives.
    Wang CY; Pan XD; Liu HY; Fu ZD; Wei XY; Yang LX
    Bioorg Med Chem; 2004 Jul; 12(13):3657-62. PubMed ID: 15186850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives].
    Pan XD; Liu HY; Sun PY; Zhu CG; Yang J; Yuan KH; Han R
    Yao Xue Xue Bao; 2004 Aug; 39(8):591-7. PubMed ID: 15563058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin.
    Saetern AM; Nguyen NB; Bauer-Brandl A; Brandl M
    Int J Pharm; 2004 Oct; 284(1-2):61-8. PubMed ID: 15454297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
    Schluep T; Cheng J; Khin KT; Davis ME
    Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.
    Zhu Y; Jiang H; Zhang C; He QJ; Yang B; Li LJ; Zhu H
    Pharmazie; 2009 Dec; 64(12):823-8. PubMed ID: 20095141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
    Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A
    Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.